°®ÍþÄÌapp

Close

°®ÍþÄÌapp reaction to paper about Ebola immunity

°®ÍþÄÌapp reaction to about Ebola immunity generated in non-human primates. The study reported the use of two vaccines to protect against Ebola virus in macaques, with protection seen up to ten months after vaccination.

, Professor of Emerging Infectious Disease at the °®ÍþÄÌapp of Hygiene & Tropical Medicine, said:

"The paper by Sullivan and colleagues describes a novel vaccine approach to Ebola that gives hope for a successful trial in humans, with the innovative prime-boost method overcoming a known limitation of this method. However, this chimpanzee adenovirus vaccine may still have an unusually large barrier to overcome when transferring to humans, so I hope these trials can begin as soon as possible. A long lasting protective immunisation process is just what is needed."

Study at LSHTM

If you enjoyed this article and would like to build a career in global health, we offer a range of MSc programmes covering health and data, infectious and tropical diseases, population health, and public health and policy

Available on campus or online, including flexible study that works around your work and home life, be part of a global community at the UK's no.1 public health university.